Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia

Clinical Cancer Research

Volumn 5, Issue 12, 1999, Pages 4041-4047

  Faderl, Stefan ^a   Thall, Peter F ^a   Kantarjian, Hagop M ^a   Talpaz, Moshe ^a   Harris, David ^a   Van, Quin ^a   Beran, Miloslav ^a   Kornblau, Steven M ^a   Pierce, Sherry ^a   Estrov, Zeev ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BILIRUBIN; CASPASE 2; CASPASE 3; CREATININE; HEMOGLOBIN; LACTATE DEHYDROGENASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; BLAST CELL; CANCER REGRESSION; CANCER SURVIVAL; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; LEUKEMOGENESIS; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOTTING, WESTERN; CASPASE 2; CASPASE 3; CASPASES; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; MALE; MIDDLE AGED; PHILADELPHIA CHROMOSOME; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGRESSION ANALYSIS; REMISSION INDUCTION; SURVIVAL ANALYSIS;

EID: 0033373258     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Yoshida, Y., Anzai, N., and Kawabata, H. Apoptosis in normal and neoplastic hematopoiesis. Crit. Rev. Oncol. Hematol., 24: 185-211, 1996.
2. Della Ragione, F., and Iolascon, A. Inactivation of cyclin-dependent kinase inhibitor genes and development of human acute leukemias. Leuk. Lymphoma, 25: 23-35, 1997.
3. Kerr, J. F., Wyllie, A. H., and Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26: 239-257, 1972.
4. Martin, S. J., and Green, D. Protease activation during apoptosis: death by a thousand cuts? Cell, 82: 340-352, 1995.
5. Allan, P. D., Bustin, S. A., and Newland, A. C. The role of apoptosis (programmed cell death) in haemopoiesis and the immune system. Blood Rev., 7: 63-73, 1993.
6. Karp, J. E. Acute leukemia: mechanisms of cell survival as targets for therapy. Int. J. Oncol., 11: 657-700, 1997.
7. Kaufman, S. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res., 49: 5870-5875, 1989.
8. Walker, P. R., Smith, C., Youdale, T., Leblanc, J., Whitfield, J. F., and Sikorska, M. Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res., 51: 1078-1085, 1991.
9. Shinomiya, N., Shinomiya, M., Wakiyama, H., Katsura, Y., and Rokutanda, M. Enhancement of CDDP cytotoxicity by caffeine is characterized by apoptotic cell death. Exp. Cell Res., 210: 236-242, 1994.
10. Huschtscha, L. I., Bartier, W. A., Ross, C. E. A., and Tattersall, M. H. N. Characteristics of cancer cell death after exposure to cytotoxic drugs in vitro. Br. J. Cancer, 73: 54-60, 1996.
11. Thronberry, N. A., and Lazebnik, Y. Caspases: enemies within. Science (Washington DC), 281: 1312-1316, 1998.
12. Ellis, R. E., Yuan, J., and Horvitz, H. R. Mechanisms and functions of cell death. Annu. Rev. Cell Biol., 7: 663-698, 1991.
13. Hengartner, M. O., and Horvitz, H. R. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell, 76: 665-676, 1994.
14. Yuan, J., Shaham, S., Ledoux, S., Ellis, H. M., and Horvitz, H. R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 β-converting enzyme. Cell, 75: 641-652, 1993.
15. Cohen, G. M. Caspases: the executioners of apoptosis. Biochem J., 326: 1-16, 1997.
16. Lazebnik. Y. A., Kaufmann, S. H., Desnoyer, S., Poirier, G. G., and Earnshaw, W. C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature (Lond.), 371: 346-347, 1994.
17. Song, Q., Lees-Miller, S. P., Kumar, S., Zhang, N., Chan, D. W., Smith, G. C. M., Jackson, S. P., Alnemri, E. S., Litwack, G., Khanna, K. K., and Lavin, M. F. DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis. EMBO J., 15: 3238-3246, 1996.
18. Ucker, D. S., Meyers, J., and Obermiller, P. S. Activation-driven T cell death. II. Quantitative differences alone distinguish stimuli triggering nontransformed T cell proliferation or death. J. Immunol., 149: 1583-1592, 1992.
19. Wang, L., Miura, M., Bergeron, L., Zhu, H., and Yuan, J. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell, 78: 739-750, 1994.
20. Tiso, N., Pallavicini, A., Murano, T., Zimbello, R., Apolloni, E., Valle, G., Lanfranchi, G., and Danielli, G. A. Chromosomal localization of the human genes, CPP32, Mch2, Mch3, and Ich-1, involved in cellular apoptosis. Biochem. Biophys. Res. Commun., 225: 983-989, 1996.
21. Li, H., Bergeron, L., Cryns, V., Pasternak, M. S., Zhu, H., Shi, L., Greenberg, A., and Yuan, J. Activation of caspase-2 in apoptosis. J. Biol. Chem., 272: 21010-21017, 1996.
22. Fernandes-Alnemri, T., Litwack, G., and Alnemri, E, S. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death Ced-3 and mammalian interleukin-1 β-converting enzyme. J. Biol. Chem., 269: 30761-30764, 1994.
23. Darmon, A. J., Nicholson, D. W., and Bleackley, R. C. Activation of the apoptotic protease CPP32 cytotoxic T-cell-derived granzyme B. Nature (Lond.), 577: 446-448, 1995.
24. Estrov, Z., Thall, P. F., Talpaz, M., Estey, E., Kantarjian, H. M., Andreeff, M., Harris, D., Van, Q., Walterscheid, M., and Kornblau, S. Caspase 2 and caspase 3 protein levels as predictors of survival in acute myelogenous leukemia. Blood, 92: 3090-3097, 1998.
25. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H. R., and Sultan, C. Proposals for the classification of acute leukemia. Br. J. Haematol., 33: 451-458, 1976.
26. Kantarjian, H., O'Brien, S., Beran, M., Keating, M., Koller, C., Robertson, L., Andreeff, M., Murphy, S., and Freireich, E. J. Update of the hyper-CVAD program in newly diagnosed adult acute lymphocytic leukemia (ALL). Blood, 86: 173a, 1995.
27. Keating, M. J., Cork, A., Broach, Y., Smith, T., Walters, R. S., McCredie, K. B., Trujillo, J., and Freireich, E. J. Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia. Leuk. Res., 11: 119-133, 1987.
28. Kornblau, S. M., Xu, H. J., Zhang, W., Hu, S. X., Beran, M., Smith, T. L., Hester, J., Estey, E., Benedict, W. F., and Deisseroth, A. B. Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood, 84: 256-261, 1994.
29. Snedecor, G. W., and Cochran, W. G. Statistical Methods, Ed. 7. Ames, IA: Iowa State University Press, 1980.
30. X2 measures the discrepancy between observation and hypothesis. J. R. Stat. Soc., 87: 442-450, 1924.
31. Mehta, C. R. The exact analysis of contingency tables in medical research. Stat. Methods Med. Res., 3: 135-156, 1994.
32. Kaplan, E. L., and Meier, P. Nonparametric estimator from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
33. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 60: 163-170, 1966.
34. Cox, D. R. Regression models and life tables (with discussion). J. R. Stat. Soc. B, 34: 187-220, 1972.
35. Fleming, T. R., and Harrington, D. P. Counting Processes and Survival Analysis. New York: John Wiley & Sons, Inc., 1991.
36. Grambsch, P. M., and Therneau, T. M. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika, 81: 515-526, 1994.
37. Cleveland, W. S. Robust locally weighted regression and smoothing scatterplots. J. Am. Stat. Assoc., 74: 829-836, 1979.
38. Lausen, B., and Schumacher, M. Maximally selected rank statistics. Biometrics, 48: 73-85, 1992.
39. Hilsenbeck, S. G., and Clark, G. M. Practical p-value adjustment for optimally selected cutpoints. Stat. Med., 15: 103-112, 1996.
40. StatXact 3 for Windows. Cambridge, MA: Cytel Corporation, 1995.
41. Therneau, T. M. A package for survival analysis in S. Mayo Clinic Foundation, 1994.
42. Faderl, S., Kantarjian, H. M., Talpaz, M., and Estrov, Z. Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood, 91: 3995-4019, 1998.
43. Hetts, S. W. To die or not to die. J. Am. Med. Assoc., 279. 300-307, 1998.
44. Krajewska, M., Wang, H-G., Krajevski, S., Zapata, J. M., Shabaik, A., Gascoyne, R., and Reed, J. C. Immunohistochemical analysis of in vitro patterns of expression of CPP32 (caspase-3), a cell death protease. Cancer Res., 57: 1605-1613, 1997.
45. Villa, P., Kaufmann, S. H., and Earnshaw, W. C. Caspases and caspase inhibitors. Trends Biochem. Sci., 22: 388-393, 1997.
46. Harvey, N. L., Butt, A. J., and Kumar, S. Functional activation of Nedd2/ICH-1 (caspase 2) is an early process in apoptosis. J. Biol. Chem., 272: 13134-13139, 1997.